Literature DB >> 27989783

The binding effectiveness of anti-r-disintegrin polyclonal antibodies against disintegrins and PII and PIII metalloproteases: An immunological survey of type A, B and A+B venoms from Mohave rattlesnakes.

Esteban Cantú1, Sahiti Mallela1, Matthew Nyguen1, Raúl Báez1, Victoria Parra1, Rachel Johnson1, Kyle Wilson1, Montamas Suntravat1, Sara Lucena1, Alexis Rodríguez-Acosta2, Elda E Sánchez3.   

Abstract

Snake venoms are known to have different venom compositions and toxicity, but differences can also be found within populations of the same species contributing to the complexity of treatment of envenomated victims. One of the first well-documented intraspecies venom variations comes from the Mohave rattlesnake (Crotalus scutulatus scutulatus). Initially, three types of venoms were described; type A venom is the most toxic as a result of ~45% Mojave toxin in the venom composition, type B lacks the Mojave toxin but contains over 50% of snake venom metalloproteases (SVMPs). Also, type A+B venom contains a combination of Mojave toxin and SVMP. The use of an anti-disintegrin antibody in a simple Enzyme-Linked Immunosorbent Assay (ELISA) can be used to identify the difference between the venoms of the type A, B, and A+B Mohave rattlesnakes. This study implements the use of an anti-recombinant disintegrin polyclonal antibody (ARDPA) for the detection of disintegrins and ADAMs (a disintegrin and metalloproteases) in individual crude snake venoms of Mohave rattlesnakes (Crotalus scutulatus scutulatus) of varying geographical locations. After correlation with Western blots, coagulation activity and LD50 data, it was determined that the antibody allows for a quick and cost-efficient identification of venom types. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibodies; Crotalus scutulatus; Disintegrin; ELISA; Venom

Mesh:

Substances:

Year:  2016        PMID: 27989783      PMCID: PMC5362346          DOI: 10.1016/j.cbpc.2016.10.009

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Toxicol Pharmacol        ISSN: 1532-0456            Impact factor:   3.228


  37 in total

1.  The efficacy of two antivenoms against the venom of North American snakes.

Authors:  Elda E Sánchez; Jacob A Galán; John C Perez; Alexis Rodríguez-Acosta; Peter B Chase; John C Pérez
Journal:  Toxicon       Date:  2003-03-01       Impact factor: 3.033

2.  Geographical pattern of crotamine distribution in the same rattlesnake subspecies.

Authors:  S SCHENBERG
Journal:  Science       Date:  1959-05-15       Impact factor: 47.728

3.  Atrolysins: metalloproteinases from Crotalus atrox venom.

Authors:  J W Fox; J B Bjarnason
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

Review 4.  Snake venom metalloproteinases.

Authors:  Francis S Markland; Stephen Swenson
Journal:  Toxicon       Date:  2012-09-18       Impact factor: 3.033

5.  Some observations on the venom of the rhinoceros horned viper, Bitis nasicornis Shaw.

Authors:  N Marsh; A Glatston
Journal:  Toxicon       Date:  1974-12       Impact factor: 3.033

6.  Toxicity of Elapidae venoms and an observation in relation to geographical location.

Authors:  R L Irwin; K L Oliver; A H Mohamed; W E Haast
Journal:  Toxicon       Date:  1970-05       Impact factor: 3.033

Review 7.  Snake venom metalloproteinases: structure, function and relevance to the mammalian ADAM/ADAMTS family proteins.

Authors:  Soichi Takeda; Hiroyuki Takeya; Sadaaki Iwanaga
Journal:  Biochim Biophys Acta       Date:  2011-04-20

8.  Intergradation of two different venom populations of the Mojave rattlesnake (Crotalus scutulatus scutulatus) in Arizona.

Authors:  J L Glenn; R C Straight
Journal:  Toxicon       Date:  1989       Impact factor: 3.033

9.  Envenomation by the Mojave rattlesnake (Crotalus scutulatus scutulatus) in southern Arizona, U.S.A.

Authors:  D L Hardy
Journal:  Toxicon       Date:  1983       Impact factor: 3.033

10.  Evidence for heterogeneous forms of the snake venom metalloproteinase jararhagin: a factor contributing to snake venom variability.

Authors:  A M Moura-da-Silva; M S Della-Casa; A S David; M T Assakura; D Butera; I Lebrun; J D Shannon; S M T Serrano; J W Fox
Journal:  Arch Biochem Biophys       Date:  2003-01-15       Impact factor: 4.013

View more
  3 in total

1.  Characterization of the Rabbit as an In Vitro and In Vivo Model to Assess the Effects of Fibrinogenolytic Activity of Snake Venom on Coagulation.

Authors:  Vance G Nielsen; Elda E Sánchez; Daniel T Redford
Journal:  Basic Clin Pharmacol Toxicol       Date:  2017-08-06       Impact factor: 4.080

2.  Rattling the border wall: Pathophysiological implications of functional and proteomic venom variation between Mexican and US subspecies of the desert rattlesnake Crotalus scutulatus.

Authors:  James Dobson; Daryl C Yang; Bianca Op den Brouw; Chip Cochran; Tam Huynh; Sanjaya Kurrupu; Elda E Sánchez; Daniel J Massey; Kate Baumann; Timothy N W Jackson; Amanda Nouwens; Peter Josh; Edgar Neri-Castro; Alejandro Alagón; Wayne C Hodgson; Bryan G Fry
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2017-10-24       Impact factor: 3.228

3.  Examination of the Efficacy and Cross-Reactivity of a Novel Polyclonal Antibody Targeting the Disintegrin Domain in SVMPs to Neutralize Snake Venom.

Authors:  Shelby S Szteiter; Ilse N Diego; Jonathan Ortegon; Eliana M Salinas; Abcde Cirilo; Armando Reyes; Oscar Sanchez; Montamas Suntravat; Emelyn Salazar; Elda E Sánchez; Jacob A Galan
Journal:  Toxins (Basel)       Date:  2021-03-31       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.